iBio (IBIO) Acquisitions (2022)
iBio (IBIO) posted quarterly Acquisitions of $692000.0 for Q3 2022.
iBio (IBIO) Acquisitions (2022) Analysis & Trends
iBio (IBIO) has reported Acquisitions for 1 consecutive years, with $692000.0 the latest figure, recorded in Q3 2022.
- In Q3 2022, Acquisitions changed N/A year-over-year to $692000.0; the TTM figure through Jun 2023 stood at $692000.0 (changed N/A YoY), while the FY2023 annual figure was $692000.0, changed N/A from the prior year.
- Acquisitions held at $692000.0 in Q3 2022 per IBIO's latest filing.
- Across five years, Acquisitions topped out at $692000.0 in Q3 2022 and bottomed at $692000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.65 Bn | 131.79 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.08 Bn | 78.09 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | - |
| 4 | Moderna | 63.25 Bn | 58.11 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.26 Bn | 27.95 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.96 Bn | 10.57 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.19 Bn | 26.35 Bn | - | - |
| 10 | iBio | 176.33 Mn | 176.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 692,000.00 |